MSH6 and thyroid cancer: A recent case–control study comprising 106 thyroid cancer patients and 212 age- and gender-matched controls revealed that MSH6 rs1042821 variant homozygotes exhibited higher risk of this cancer (OR = 3.42, CI = 1.04–11.24, p = 0.04).